Study to Evaluate the Safety and Efficacy of CNTX-4975 in Subjects With Chronic, Moderate to Severe Osteoarthritis Knee Pain

PHASE2CompletedINTERVENTIONAL
Enrollment

175

Participants

Timeline

Start Date

August 31, 2015

Primary Completion Date

October 31, 2016

Study Completion Date

February 28, 2017

Conditions
Osteoarthritis
Interventions
DRUG

CNTX-4975

OTHER

Placebo

Trial Locations (22)

10016

Manhattan Medical Research Practice, New York

10530

Drug Trials America, Hartsdale

16602

University Orthopedics Center, Altoona

16635

Altoona Center for Clinical Research, Duncansville

16801

University Orthopedics Center, State College

27612

Wake Research Associates, LLC, Raleigh

30281

Clinical Research Atlanta, Stockbridge

32162

Compass Research, LLC, The Villages

32720

Avail Clinical Research, LLC, DeLand

32806

Compass Research, LLC, Orlando

33012

Finlay Research Clinic, Hialeah

33013

Eastern Research, Hialeah

33319

Sunrise Medical Research, Lauderdale Lakes

35216

Achieve Clinical Research, LLC, Birmingham

64114

The Center for Pharmaceutical Research, Kansas City

85704

Advanced Arizona Clinical Research, Tucson

M&M Medical Center, Inc, Miami

90036

Axis Clinical Trials, Los Angeles

91303

Hope Clinical Research, LLC, Canoga Park

91941

BioSolutions Clinical Research Center, La Mesa

92020

TriWest Research Associates, El Cajon

92801

Dream Team Clinical Research, LLC, Anaheim

Sponsors
All Listed Sponsors
lead

Centrexion Therapeutics

INDUSTRY